Executive Panel: Recent Advances and Future Perspectives for AI in the Drug Discovery and Development Value Chain | Kisaco Research
Sponsor(s): 
MilliporeSigma
Speaker(s): 
Moderator

Author:

David Champagne

Senior Partner
McKinsey & Company

David Champagne is a Senior Partner at McKinsey and leads McKinsey’s global Scientific AI practice to help clients in the life sciences industry and beyond drive the next frontier of R&D productivity with AI. The practice covers a broad range of AI capabilities across Biology, Chemistry, Materials and Physics. David brings together teams of scientific experts from McKinsey’s industry practices with deep technology expertise from QuantumBlack, to develop strategies, blueprints and roadmaps for the technology-driven transformation of product discovery and development processes in industries where science is at the core of innovation.

David Champagne

Senior Partner
McKinsey & Company

David Champagne is a Senior Partner at McKinsey and leads McKinsey’s global Scientific AI practice to help clients in the life sciences industry and beyond drive the next frontier of R&D productivity with AI. The practice covers a broad range of AI capabilities across Biology, Chemistry, Materials and Physics. David brings together teams of scientific experts from McKinsey’s industry practices with deep technology expertise from QuantumBlack, to develop strategies, blueprints and roadmaps for the technology-driven transformation of product discovery and development processes in industries where science is at the core of innovation.

Author:

Melissa Landon

Head, Commercial & Business Development, AI & Automation
MilliporeSigma

Melissa Landon

Head, Commercial & Business Development, AI & Automation
MilliporeSigma

Author:

David Hallett

Chief Scientific Officer
Recursion

David Hallett

Chief Scientific Officer
Recursion

Author:

Morten Sogaard

Senior Vice President & Head, Astellas Innovation Lab
Astellas Pharma

Morten Sogaard

Senior Vice President & Head, Astellas Innovation Lab
Astellas Pharma

Author:

Peter Clark

Vice President, Digital Chemistry & Design
Novo Nordisk RDUS

Peter Clark

Vice President, Digital Chemistry & Design
Novo Nordisk RDUS
Time: 
9:00 AM - 9:45 AM
Session Type: 
Panel